This memorandum places into the public scientific record an empirical validation of the bivariate scaling law Vₑₐₒ(μ, σ) = μ^γ • F(σ/μ^κ) in human cardiac dynamics, using open-access electrocardiographic data from the PhysioNet repository. Using a proprietary extraction mechanism calibrated for biological oscillators, the scaling relationship was applied to ten subjects drawn from two clinically distinct cohorts: five healthy individuals and five individuals diagnosed with congestive heart failure (CHF). Across 444,118 healthy beats and approximately 537,000 CHF beats, the bivariate scaling law was found to hold in both populations, with healthy subjects exhibiting a mean goodness-of-fit of R² = 0.9279 ± 0.017 and CHF subjects exhibiting R² = 0.9004 ± 0.013. A statistically significant reduction in geometric integrity (R²; p = 0.031) was observed in the diseased cohort, alongside a trend toward exponent migration in the scaling exponent p (p = 0.066). These results are consistent with the theoretical prediction that diseased biological oscillators undergo a measurable shift in their stochastic scaling structure as system integrity degrades. This document establishes a timestamped empirical baseline for the cardiac application of the RGL framework and connects these findings to the Biological Feigenbaum Spectrum (BFS) established in prior work (Romberger, 2026).